Participants must be able to sufficiently speak and understand English so as to be able to understand and complete cognitive tasks.
All subjects must have the ability to give valid informed consent.
Diagnosis of schizophrenia, schizophreniform or schizoaffective disorder
No medication changes in the prior month
No medication changes anticipated in the upcoming month
Stable outpatient or partial hospital status
Normal IQ (\>70; IQ will be measured by administering the Wechsler Abbreviated Scale of
Intelligence (WASI) test)
Must not be currently taking the antipsychotic clozapine
You may not be if
Pacemakers
Implanted electrical (brain and spinal) stimulators
Implanted defibrillator
Metallic implants
Skin damage or skin conditions such as eczema at the sites where electrodes will be placed
Hair styles hindering the placement of electrodes
Cranial pathologies
Head trauma
Epilepsy
Mental retardation
Any known history of neurological disorders (including epilepsy, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), stroke, cerebral palsy, any DSM-5 axis I psychiatric disorder (for healthy control subjects), autism)
Uncorrected vision problems that would hinder cognitive testing (this also pertains to subjects with color blindness in tasks where discriminating colored objects/items is necessary for successful performance)
Pregnancy
Substance dependence in the past six months
Substance abuse in the past month
Clareo Health | Effects of Brain Stimulation on Cognition, Oscillations and GABA Levels in Schizophrenia
